ABIN1383943

antibody from antibodies-online

Targeting: IL4 BCGF-1, BCGF1, BSF1, IL-4, MGC79402

No application information provided.

Antibody Data

Product number

ABIN1383943

Provider

antibodies-online

Product name

anti-Interleukin 4 (IL4) antibody

Antibody type

Monoclonal

Antigen

Other

Description

Ion exchange chromatography

Reactivity

Human

Host

Mouse

Isotype

IgG

Antibody clone number

B-S4

Vial size

500μl

Concentration

500μg/500μl

Storage

Declared stable after 7 days at room temperature. Protect from light. Do not freeze.

References

Submitted references

Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells.

Koido S, Hara E, Homma S, Mitsunaga M, Takahara A, Nagasaki E, Kawahara H, Watanabe M, Toyama Y, Yanagisawa S, Kobayashi S, Yanaga K, Fujise K, Gong J, Tajiri H
Journal of immunology (Baltimore, Md. : 1950) 2007 Oct 1;179(7):4874-83

---

Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells.

Koido S, Hara E, Homma S, Torii A, Mitsunaga M, Yanagisawa S, Toyama Y, Kawahara H, Watanabe M, Yoshida S, Kobayashi S, Yanaga K, Fujise K, Tajiri H
Journal of immunology (Baltimore, Md. : 1950) 2007 Jan 1;178(1):613-22

---

Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism.

Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Powell WS, Monneret G
Journal of immunology (Baltimore, Md. : 1950) 2006 Nov 1;177(9):6540-7

---

Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells.

Todaro M, Zerilli M, Ricci-Vitiani L, Bini M, Perez Alea M, Maria Florena A, Miceli L, Condorelli G, Bonventre S, Di Gesù G, De Maria R, Stassi G
Cancer research 2006 Feb 1;66(3):1491-9

---

Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.

Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G
Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Nov 1;11(21):7891-900

---

IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins.

Conticello C, Pedini F, Zeuner A, Patti M, Zerilli M, Stassi G, Messina A, Peschle C, De Maria R
Journal of immunology (Baltimore, Md. : 1950) 2004 May 1;172(9):5467-77

---

Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10.

Stassi G, Todaro M, Zerilli M, Ricci-Vitiani L, Di Liberto D, Patti M, Florena A, Di Gaudio F, Di Gesù G, De Maria R
Cancer research 2003 Oct 15;63(20):6784-90